Rudolph Emile Tanzi, Ph.D.
Co-Author
This page shows the publications co-authored by Rudolph Tanzi and Ana Griciuc.
Connection Strength
3.040
-
The role of innate immune genes in Alzheimer's disease. Curr Opin Neurol. 2021 04 01; 34(2):228-236.
Score: 0.929
-
TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease. Neuron. 2019 09 04; 103(5):820-835.e7.
Score: 0.824
-
Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013 May 22; 78(4):631-43.
Score: 0.536
-
Evaluation of Fluorinated Cromolyn Derivatives as Potential Therapeutics for Alzheimer's Disease. J Alzheimers Dis. 2021; 80(2):775-786.
Score: 0.228
-
Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation. Hum Mol Genet. 2020 10 10; 29(17):2920-2935.
Score: 0.225
-
Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid ß-Protein by Promoting Microglial Phagocytosis. Sci Rep. 2018 01 18; 8(1):1144.
Score: 0.186
-
Astrocytic interleukin-3 programs microglia and limits Alzheimer's disease. Nature. 2021 07; 595(7869):701-706.
Score: 0.059
-
Cromolyn sodium delays disease onset and is neuroprotective in the SOD1G93A Mouse Model of amyotrophic lateral sclerosis. Sci Rep. 2019 11 27; 9(1):17728.
Score: 0.053
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.